Introduction
Insoluble (particulate) beta-glucans
Immunological effects of beta-glucans
Effects on host immune defence
Potential anti-cancer effects
Dose–response considerations
References | Immunological effect studied | Type of beta-glucans studied and context | Beta-glucan concentrations evaluated | Lowest beta-glucan concentration at which any effects were detected |
---|---|---|---|---|
[41] | Mixed lymphocyte reactions between monocyte-derived dendritic cells and allogeneic naïve CD4+ T cells Expression of Jagged1 mRNA | Curdlan (beta-glucan derived from C. albicans) Moncyte-derived dendritic cells and T cells from PBMCs from healthy donors Phorbol myristate acetate (PMA)-differentiated THP-1 macrophages (derived from a leukaemia cell line) | 0.1–100 ng/mL (for 48 h) | 0.1 ng/mL of curdlan led to production of IL-17 by dendritic cells in mixed lymphocyte reaction assays (production most marked at 1 ng/mL), but curdlan had no effect on IFN-ɣ or IL-5 production 10–100 ng/mL (but not 1 ng/mL) increased Jagged1 mRNA expression in dendritic cells, but a concentration of 10 µg/mL was needed in PMA-stimulated THP-1 cells (macrophages derived from a human monocytic leukaemia cell line) |
[42] | Splenocyte proliferation Macrophage cytokine production (IL-1β, IFN-ɣ, IL-12) Macrophage and NK cell tumouricidal activity | Beta-glucans from mutated and wild-type S. cerevisiae (yeast) (beta-glucans from mutant yeast is known to contain more mannose than beta-glucans from wild-type yeast) Mouse splenocytes and peritoneal macrophages | 0.01–100 µg/mL | 0.01 µg/mL (= 10 ng/mL) of mutant (but not wild-type) beta-glucans induced detectable splenocyte proliferation and IL-1β and IL-12 production from macrophages; higher concentrations needed for TNFα and IFN-ɣ induction. Higher concentrations also needed for induction of any cytokine or splenocyte proliferation by wild-type beta-glucan |
[43] | Cytokine release Oxidative burst response Microbicidal activity Activation of a NF-kB-like factor | Yeast-derived soluble beta-glucan (PGG glucan) Whole blood and purified subpopulations of PBMCs from healthy volunteers | 0.1–100 µg/mL | 0.1 µg/mL (= 100 ng/mL) enhanced the leucocyte oxidative burst response and microbial killing of whole blood, but concentrations up to 100 µg/mL did not result in cytokine release from PBMCs (IL-1α, IL-1β, IL-6, IL-8 and TNF-α); activation of an NF-kB-like factor was detectable at 0.37 µg/mL and above |
[44] | Activation and maturation of immature dendritic cells measured by Cell surface expression of CD80, CD86, CD83, CD40, CD54 and HLA-DR Production of interleukin IL-12 and IL-10 (proteins and mRNA expression) Capacity for endocytosis (a marker of immaturity) Ability to cause T cell stimulation (as measured by T cell secretion of IFN-ɣ and IL-10 after co-incubation) IκB and p38 MAPK phosphorylation,and NF- κB translocation | Beta-glucans from Ganoderma lucidum (Lingzhi or Reishi mushrooms used in Chinese/Japanese herbal medicines) Human monocyte-derived dendritic cells and T cells from healthy donors | 0.2–200 µg/mL | Concentrations of beta-glucans as low as 0.2 µg/mL (200 ng/mL) enhanced production of IL-12 p40, and IL-10 from dendritic cells (lower concentrations not tested); much higher cytokine production was stimulated by 10 µg/mL 10 µg/mL induced maturation of dendritic cells (assessed by cell membrane markers) (lower concentrations not tested) Endocytic activity of dendritic cells was suppressed by 10 µg/mL for 24 h (other concentrations not tested) After exposure to 10 µg/mL for 24 h, dendritic cells enhanced T cell proliferation and activation, as evidenced by T cell secretion of IFN-ɣ and IL-10 (other concentrations not tested) 10 µg/mL for 30 min induced MAPK phosphorylation; 10 µg/mL for 60 min induced IκB phosphorylation; and 10 µg/mL for 2 h induced NFKB translocation to the nucleus (all indicators of dendritic cell maturation) (lower concentrations not tested) |
[47] | Neutrophil migration/chemotaxis | Highly purified beta-glucans of different structures, derived from different sources, including yeast (Candida albicans-derived beta-glucans), fungi (including lentinan, grifolan and sonifilan), bacteria (curdlan) and algae (laminarin) Human neutrophils from healthy donors | 0.1–200 μg/mL | Concentrations of Candida albicans-derived beta-glucans ≥1 μg/mL significantly enhanced neutrophil migration/chemotaxis (no enhancement seen at 0.1 μg/mL). None of the other beta-glucans, even at 200 μg/mL, enhanced neutrophil migration |
[45] | PBMC proliferation Phenotypic and functional maturation of dendritic cells, including IL-12 and IL-10 production | Beta-glucans from mycelium and spores of Ganoderma lucidum, and from barley (different sources and purity) Monocyte-derived dendritic cells and T cells from PBMCs from healthy donors | 1–1000 μg/mL | Beta-glucans concentrations between 1 and 10 μg/mL stimulated PBMC proliferation, depending on the source of beta-glucans (a 10-fold difference in potency) 100 μg/mL for 48 h stimulated dendritic cell maturation based on cell surface markers (lower concentrations not tested) |
[48] | Histamine release from human blood leucocytes | Curdlan, laminarin, scleroglucan and pustulan (structurally diverse beta-glucans) Leucocytes (including 2 % basophils) from healthy donors and donors allergic to house dust mite | 10 ng/mL–100 µg/mL | None of the beta-glucans triggered histamine release at any concentration. However, 1 µg/mL of laminarin, 10 µg/mL of pustulan, 100 µg/mL of curdlan and 300 µg/mL of scleroglucan potentiated anti-IgE antibody-mediated histamine release; 10 µg/mL of laminarin potentiated mite-allergen-induced histamine release in cells from an allergic subject |
[46] | IL-1, TNFα and PGE2 production Antigen presentation T4 cell proliferation | Soluble (aminated) beta-glucan of yeast origin Human PBMCs from healthy donors | 3–100 µg/mL | 3 µg/mL of beta-glucan resulted in intracellular and membrane-associated IL-1 production, but 25 µg/mL was required for secretion of IL-1. PGE2 production was detected at levels as low as 12.5 µg/mL (lower concentrations not tested). TNFα production was detected at 25 µg/mL (lower levels not tested). No effects on antigen presentation or T4 proliferation were detected at levels up to 100 µg/mL |
[49] | Cytotoxic activity of polymorphonuclear and other cells against tumour cells | 28 immunomodulators, including lentinan and beta-glucans from other sources Mouse macrophages, polymorphonuclear cells, splenocytes and thymus cells 5 tumour cell lines | 0.1–100 µg/mL | Lentinan did not induce cytotoxicity at any dose up to 100 µg/mL. However, a linear β-1,3-glucans without branching or carboxymethyl groups was highly effective, inducing ~100 % cytotoxicity at 6.3 µg/mL and above (0.1, 0.4 and 1.6 µg/mL also tested) |
[25] | AKT signalling pathway, ERK and c-Raf phosphorylation Cytokine and chemokine secretion (CD54, IL-1α, IL-1β, IL-16, IL-17, IL-23, IFN-γ, CCL1, CCL3, CCL4, CCL12, CXCL10, TIMP-1 and G-CSF) by mouse macrophages Cytokine and chemokine secretion (IL-6, CCL2, CCL3, CCL5, CXCL1 and MIF) by human PBMCs | β-glu6, a synthetic analogue of the lentinan basic unit Mouse peritoneal macrophages and human PBMCs from healthy donors | 10–1000 µg/mL | β-glu6 suppressed AKT phosphorylation at 10, 25 and 50 µg/mL (lower concentrations not tested), but suppression only considered significant at 100 µg/mL. Modulation of other AKT pathway components, ERK 1/2 pathway, and cytokine/chemokine production by mouse macrophages and human PBMCs demonstrated at 100 µg/mL (lower concentrations not tested) |
[50] | Inflammation-related gene expression kinetics (IL-1, IL-8, NF-kB and IL-10) | Beta-glucans from different sources (oat, barley and shiitake mushrooms) and of different purity/processings PMA-differentiated THP-1 macrophages | 100 µg/mL | All tested beta-glucans mildly upregulated the inflammation-related genes with differential gene expression patterns (only 100 µg/mL seems to have been tested). No effect was detected on production of nitric oxide, hydrogen peroxide or phagocytic activity |
[51] | Induction of TNFα and IFN-ɣ | Beta-glucans from Ganoderma lucidum PBMCs from a healthy donor | 3.25–400 µg/mL | Moderate TNFα induction detected in 5/5 samples at 100 µg/mL or above but in only 2/5 samples below 100 µg/mL. Low level IFN- ɣ induction detected in 2 of 5 samples at 100 µg/mL (but not at 12.5 µg/mL) |